CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

non-invasive CCTA

3 min read

Catching Plaque Early Guides Personalized Treatment and Tracking of Heart Disease

Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive evaluation of atherosclerotic plaque for guiding personalized treatment and tracking is changing the...

Read More »

3 min read

How Cleerly Outperforms Stress Tests

Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.

Read More »

7 min read

Cleerly Personalized Care Pathway is Transforming Heart Health

The current approach to cardiovascular care is flawed for two reasons. One is the lack of a disease-based care paradigm with a focus on actual heart disease–atherosclerosis– in lieu of an emphasis on symptom-driven care that identifies only late-stage...

Read More »

3 min read

SCCT 2022: Defining the Future of Cardiovascular CT

Last week, our team at Cleerly had the opportunity to take part in a gathering of impassioned cardiac computed tomography (CT) leaders at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Las Vegas. As the former...

Read More »

3 min read

Cleerly Analysis Offers Critical Insight on Heart Health

Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care, emphasizing comprehensive evaluation of atherosclerotic plaque and heart attack prevention, is changing the approach to heart health.

Read More »

2 min read

When It's Good to Find Something Bad

For the last 50 years, cardiology care has focused on treating symptoms of heart disease, rather than its root cause - atherosclerosis. At Cleerly, we are transforming the approach to cardiovascular care with our precision health model that proactively...

Read More »